In the SURPASS-2 trial, which compared tirzepatide to semaglutide 1 mg (a GLP-1 receptor agonist) over 40 weeks, participants receiving tirzepatide achieved A1C reductions of 2.01%, 2.24%, and 2.30% from baseline with the 5 mg, 10 mg, and 15 mg weekly doses, respectively
We also offer ongoing support and monitoring, including regular check-ins to assess progress and side effects, telemedicine options for convenient follow-ups, and access to a dedicated care team for questions and concerns
How Much Does Semaglutide GLP-1 Cost in Plano, TX
SAY GOODBYE TO EXCESS WEIGHT Discover how semaglutide weight loss can change your life
GLP-1 therapy requires sustained monitoring for pancreatitis risk, dehydration, rapid weight loss complications, and medication interactions